DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 29, Issue 4, 2015, Pages 607-619

  Suntharalingham, Jenifer P ^a   Buonocore, Federica ^a   Duncan, Andrew J ^a   Achermann, John C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

46,XY disorders of sex development; Addison disease; DAX 1; hypogonadotropic hypogonadism; hypospadias; infertility; primary adrenal insufficiency; primary ovarian insufficiency; SF 1; X linked adrenal hypoplasia congenita

Indexed keywords

NUCLEAR RECEPTOR DAX 1; STEROIDOGENIC FACTOR 1; NR0B1 PROTEIN, HUMAN; NR5A1 PROTEIN, HUMAN;

ADDISON DISEASE; ADRENAL GLAND; ANDROGEN SYNTHESIS; ANORCHIA; ARTICLE; CRYPTORCHISM; DISORDER OF SEX DEVELOPMENT; FRAMESHIFT MUTATION; GENETIC COUNSELING; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPLASIA; HYPOSPADIAS; MALE INFERTILITY; MEDICAL INFORMATION; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REPRODUCTION; ADRENAL INSUFFICIENCY; GENETICS; MALE; METABOLISM; MUTATION; PATHOLOGY; X CHROMOSOME LINKED DISORDER;

ADRENAL INSUFFICIENCY; DAX-1 ORPHAN NUCLEAR RECEPTOR; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION; PHENOTYPE; STEROIDOGENIC FACTOR 1;

EID: 84940439264     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2015.07.004     Document Type: Review

References (72)

1. H. Sikl Addison's disease due to congenital adrenal hypoplasia of the adrenals in an infant aged 33 days J Pathol Bacteriol 60 1948 323 326
2. F. Muscatelli, T.M. Strom, A.P. Walker, and et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism Nature 372 1994 672 676
3. B. Bardoni, E. Zanaria, S. Guioli, and et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal Nat Genet 7 4 1994 497 501
4. E. Zanaria, F. Muscatelli, B. Bardoni, and et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita Nature 372 1994 635 641
5. E.P. Sablin, A. Woods, I.N. Krylova, and et al. The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 Proc Natl Acad Sci USA 105 2008 18390 18395
6. M. Ito, R. Yu, and J.L. Jameson DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita Mol Cell Biol 17 1997 1476 1483
7. R.N. Yu, M. Ito, T.L. Saunders, and et al. Role of Ahch in gonadal development and gametogenesis Nat Genet 20 1998 Dec 353 357
8. J.O. Scheys, J.H. Heaton, and G.D. Hammer Evidence of adrenal failure in aging Dax1-deficient mice Endocrinology 152 2011 3430 3439
9. E. Lalli, and P. Sassone-Corsi DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation Mol Endocrinol 17 2003 1445 1453
10. B. Ferraz-de-Souza, F. Martin, D. Mallet, and et al. CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease J Clin Endocrinol Metab 94 2009 678 683
11. B. Xu, W.H. Yang, I. Gerin, and et al. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis Mol Cell Biol 29 2009 1719 1734
12. A.T. Reutens, J.C. Achermann, M. Ito, and et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita J Clin Endocrinol Metab 84 1999 504 511
13. S.B. Seminara, J.C. Achermann, M. Genel, and et al. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females J Clin Endocrinol Metab 84 1999 4501 4509
14. G. Mantovani, E. De Menis, G. Borretta, and et al. DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients Eur J Endocrinol 154 2006 685 689
15. E. Wiltshire, J. Couper, C. Rodda, and et al. Variable presentation of X-linked adrenal hypoplasia congenita J Pediatr Endocrinol Metab 14 2001 1093 1096
16. Z. Landau, A. Hanukoglu, J. Sack, and et al. Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations Clin Endocrinol (Oxf) 72 2010 448 454
17. J.C. Achermann, W.X. Gu, T.J. Kotlar, and et al. Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay J Clin Endocrinol Metab 84 1999 Dec 4497 4500
18. S. Domenice, A.C. Latronico, V.N. Brito, and et al. Adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene J Clin Endocrinol Metab 86 2001 4068 4071
19. A. Tabarin, J.C. Achermann, D. Recan, and et al. A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism J Clin Invest 105 2000 321 328
20. G. Ozisik, G. Mantovani, J.C. Achermann, and et al. An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita J Clin Endocrinol Metab 88 2003 417 423
21. G. Mantovani, G. Ozisik, J.C. Achermann, and et al. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita J Clin Endocrinol Metab 87 2002 44 48
22. M. Guclu, L. Lin, E. Erturk, and et al. Puberty, stress and sudden death Lancet 376 2010 1512
23. M.L. Raffin-Sanson, B. Oudet, S. Salenave, and et al. A man with a DAX1/NR0B1 mutation, normal puberty, and an intact hypothalamic-pituitary-gonadal axis but deteriorating oligospermia during long-term follow-up Eur J Endocrinol 168 2013 K45 K50
24. G. Mantovani, M. Mancini, G. Gazzano, and et al. Somatic mutational analysis of DAX1 in testes from men with idiopathic azoospermia Fertil Steril 84 2005 1542 1544
25. M.G. Shaikh, L. Boyes, H. Kingston, and et al. Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita J Med Genet 45 2008 e1
26. J.C. Achermann, B.L. Silverman, R.L. Habiby, and et al. Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1 J Pediatr 137 2000 878 881
27. L. Lin, W.X. Gu, G. Ozisik, and et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience J Clin Endocrinol Metab 91 2006 3048 3054
28. J.C. Achermann, M. Ito, B.L. Silverman, and et al. Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression J Clin Endocrinol Metab 86 2001 3171 3175
29. Y.H. Zhang, W. Guo, R.L. Wagner, and et al. DAX1 mutations map to putative structural domains in a deduced three-dimensional model Am J Hum Genet 62 1998 855 864
30. P. Bernard, L. Ludbrook, G. Queipo, and et al. A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female Mol Genet Metab 88 2006 272 279
31. C. Frapsauce, C. Ravel, M. Legendre, and et al. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation Hum Reprod 26 2001 724 728
32. D.A. Rice, A.R. Mouw, A.M. Bogerd, and et al. A shared promoter element regulates the expression of three steroidogenic enzymes Mol Endocrinol 5 1991 1552 1561
33. K. Morohashi, S. Honda, Y. Inomata, and et al. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s J Biol Chem 267 1991 17913 17919
34. X. Luo, Y. Ikeda, and K.L. Parker A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation Cell 77 1994 481 490
35. M. Ito, J.C. Achermann, and J.L. Jameson A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes J Biol Chem 275 2000 31708 31714
36. G.D. Hammer, I. Krylova, Y. Zhang, and et al. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress Mol Cell 3 1999 521 526
37. F.Y. Lee, E.J. Faivre, M. Suzawa, and et al. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development Dev Cell 21 2011 315 327
38. R.D. Blind, E.P. Sablin, K.M. Kuchenbecker, and et al. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1 Proc Natl Acad Sci USA 111 2014 15054 15059
39. K. Shinoda, H. Lei, H. Yoshii, and et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice Dev Dyn 204 1995 22 29
40. G. Majdic, M. Young, E. Gomez-Sanchez, and et al. Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity Endocrinology 143 2002 607 614
41. M.L. Bland, C.A. Jamieson, S.F. Akana, and et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response Proc Natl Acad Sci USA 97 2000 14488 14493
42. C. Pelusi, Y. Ikeda, M. Zubair, and et al. Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells Biol Reprod 79 2008 1074 1083
43. B. Ferraz-de-Souza, L. Lin, S. Shah, and et al. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland FASEB J 25 2001 1166 1175
44. B. Ferraz-de-Souza, R.E. Hudson-Davies, L. Lin, and et al. Sterol O-acyltransferase 1 (SOAT1, ACAT) is a novel target of steroidogenic factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal J Clin Endocrinol Metab 96 2011 E663 E668
45. T. Baba, H. Otake, T. Sato, and et al. Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1 Nat Commun 5 2014 3634
46. E. Lalli, M. Doghman, P. Latre de Late, and et al. Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics Mol Cell Endocrinol 371 2013 154 159
47. J.C. Achermann, M. Ito, M. Ito, and et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans Nat Genet 22 1999 125 126
48. J.C. Achermann, G. Ozisik, M. Ito, and et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner J Clin Endocrinol Metab 87 2002 1829 1833
49. A. Biason-Lauber, and E.J. Schoenle Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency Am J Hum Genet 67 2000 1563 1568
50. R.V. Correa, S. Domenice, N.C. Bingham, and et al. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency J Clin Endocrinol Metab 89 2004 1767 1772
51. L. Lin, P. Philibert, and B. Ferraz-de-Souza Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function J Clin Endocrinol Metab 92 2007 991 999
52. B. Kohler, L. Lin, B. Ferraz-de-Souza, and et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency Hum Mutat 29 2008 59 64
53. S. Allali, J.-B. Muller, R. Brauner, and et al. Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46,XY disorders of sex development (DSD) including hypospadias PLoS ONE 6 2011 e24117
54. R. Coutant, D. Mallet, N. Lahlou, and et al. Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome J Clin Endocrinol Metab 92 2007 2868 2873
55. J.Y. Wu, I.N. McGown, L. Lin, and et al. A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development Clin Endocrinol (Oxf) 78 2013 545 550
56. M. Cools, P. Hoebeke, K.P. Wolffenbuttel, and et al. Pubertal androgenization and gonadal histology in two 46,XY adolescents with SF-1 mutations and predominantly female phenotype at birth Eur J Endocrinol 166 2012 341 346
57. S. Tantawy, L. Lin, I. Akkurt, and et al. Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations Eur J Endocrinol 167 2012 125 130
58. D. Zangen, Y. Kaufman, E. Banne, and et al. Testicular differentiation factor SF-1 is required for human spleen development J Clin Invest 124 2014 2071 2075
59. B. Kohler, L. Lin, I. Mazen, and et al. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency Eur J Endocrinol 161 2009 237 242
60. P. Philibert, D. Zenaty, L. Lin, and et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study Hum Reprod 22 2007 3255 3261
61. A. Bashamboo, B. Ferraz-de-Souza, D. Lourenco, and et al. Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1 Am J Hum Genet 87 2010 505 512
62. A. Röpke, A.C. Tewes, J. Gromoll, and et al. Comprehensive sequence analysis of the NR5A1 gene encoding steroidogenic factor 1 in a large group of infertile males Eur J Hum Genet 21 2013 1012 1015
63. A. Ferlin, M.S. Rocca, C. Vinanzi, and et al. Mutational screening of NR5A1 gene encoding steroidogenic factor 1 (SF-1) in cryptorchidism and male factor infertility and functional analysis of seven undescribed mutations Fertil Steril 104 2015 163 169
64. D. Lourenco, R. Brauner, L. Lin, and et al. Mutations in NR5A1 associated with ovarian insufficiency N Engl J Med 360 2009 1200 1210
65. N. Camats, A.V. Pandey, M. Fernández-Cancio, and et al. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals J Clin Endocrinol Metab 97 2012 E1294 E1306
66. F. Janse, L.M. de With, K.J. Duran, and et al. Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI) Fertil Steril 97 2012 141 146
67. A. Voican, A. Bachelot, J. Bouligand, and et al. NR5A1 (SF-1) mutations are not a major cause of primary ovarian insufficiency J Clin Endocrinol Metab 98 2013 E1017 E1021
68. M.Q. Almeida, I.C. Soares, T.C. Ribeiro, and et al. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults J Clin Endocrinol Metab 95 2010 1458 1462
69. S. Sbiera, S. Schmull, G. Assie, and et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors J Clin Endocrinol Metab 95 2010 E161 E171
70. R.M. Calvo, M. Asuncion, D. Telleria, and et al. Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women J Clin Endocrinol Metab 86 2001 1746 1749
71. M. Barbaro, M. Cools, L.H.J. Looijenga, and et al. Partial deletion of the NR5A1 (SF1) gene detected by synthetic probe MLPA in a patient with XY gonadal disorder of sex development Sex Dev 5 2011 181 187
72. S. Schlaubitz, S.A. Yatsenko, L.D. Smith, and et al. Ovotestes and XY sex reversal in a female with an interstitial 9q33.3-q34.1 deletion encompassing NR5A1 and LMX1B causing features of Genitopatellar syndrome Am J Med Genet A 143A 2007 1071 1081